A recent study highlights that brain-derived plasma p-tau217 demonstrates an enhanced dynamic range for detecting neuropathological changes in Alzheimer's disease. This biomarker could improve early diagnosis and monitoring of disease progression.
brain derived plasma p tau217 shows enhanced dynamic range for alzheimer s disease neuropathological change
Original title: “Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change.”